Banks - Regional
Compare Stocks
5 / 10Stock Comparison
UCB vs SFNC vs HOMB vs SRCE vs GABC
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
UCB vs SFNC vs HOMB vs SRCE vs GABC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $4.02B | $3.09B | $5.29B | $1.79B | $1.66B |
| Revenue (TTM) | $1.54B | $627M | $1.45B | $600M | $487M |
| Net Income (TTM) | $328M | $-398M | $458M | $161M | $113M |
| Gross Margin | 66.0% | 5.8% | 65.6% | 70.3% | 70.2% |
| Operating Margin | 27.5% | -84.2% | 36.0% | 34.2% | 28.7% |
| Forward P/E | 11.2x | 10.3x | 10.8x | 10.9x | 11.6x |
| Total Debt | $205M | $641M | $1.20B | $341M | $183M |
| Cash & Equiv. | $203M | $380M | $910M | $69M | $72M |
UCB vs SFNC vs HOMB vs SRCE vs GABC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| United Community Ba… (UCB) | 100 | 170.6 | +70.6% |
| Simmons First Natio… (SFNC) | 100 | 124.0 | +24.0% |
| Home Bancshares, In… (HOMB) | 100 | 184.9 | +84.9% |
| 1st Source Corporat… (SRCE) | 100 | 213.3 | +113.3% |
| German American Ban… (GABC) | 100 | 140.7 | +40.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UCB vs SFNC vs HOMB vs SRCE vs GABC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, UCB doesn't own a clear edge in any measured category.
SFNC has the current edge in this matchup, primarily because of its strength in value and dividends.
- Lower P/E (10.3x vs 11.6x)
- 4.0% yield, 6-year raise streak, vs SRCE's 2.1%
HOMB is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 21 yrs, beta 0.82, yield 2.8%
- Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner)
- Efficiency ratio 0.3% vs SFNC's 0.9%
SRCE is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 154.9% 10Y total return vs GABC's 146.5%
- PEG 0.71 vs HOMB's 3.55
- NIM 3.8% vs SFNC's 2.9%
- +24.9% vs HOMB's -1.9%
GABC ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 54.5%, EPS growth 8.1%
- Lower volatility, beta 0.74, Low D/E 15.7%, current ratio 0.18x
- Beta 0.74, yield 2.7%, current ratio 0.18x
- 54.5% NII/revenue growth vs SFNC's -56.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 54.5% NII/revenue growth vs SFNC's -56.7% | |
| Value | Lower P/E (10.3x vs 11.6x) | |
| Quality / Margins | Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner) | |
| Stability / Safety | Beta 0.74 vs SFNC's 1.02, lower leverage | |
| Dividends | 4.0% yield, 6-year raise streak, vs SRCE's 2.1% | |
| Momentum (1Y) | +24.9% vs HOMB's -1.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs SFNC's 0.9% |
UCB vs SFNC vs HOMB vs SRCE vs GABC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
UCB vs SFNC vs HOMB vs SRCE vs GABC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SRCE leads in 2 of 6 categories
SFNC leads 1 • UCB leads 0 • HOMB leads 0 • GABC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SFNC and HOMB each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
UCB is the larger business by revenue, generating $1.5B annually — 3.2x GABC's $487M. HOMB is the more profitable business, keeping 27.7% of every revenue dollar as net income compared to SFNC's -63.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $627M | $1.5B | $600M | $487M |
| EBITDAEarnings before interest/tax | $457M | -$497M | $601M | $163M | $167M |
| Net IncomeAfter-tax profit | $328M | -$398M | $458M | $161M | $113M |
| Free Cash FlowCash after capex | $408M | $755M | $354M | $152M | $154M |
| Gross MarginGross profit ÷ Revenue | +66.0% | +5.8% | +65.6% | +70.3% | +70.2% |
| Operating MarginEBIT ÷ Revenue | +27.5% | -84.2% | +36.0% | +34.2% | +28.7% |
| Net MarginNet income ÷ Revenue | +21.4% | -63.4% | +27.7% | +26.4% | +23.1% |
| FCF MarginFCF ÷ Revenue | +26.5% | +71.7% | +29.1% | +35.5% | +31.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +16.4% | +42.1% | +26.0% | +7.2% | +21.8% |
Valuation Metrics
SFNC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, SRCE trades at a 21% valuation discount to GABC's 14.4x P/E. Adjusting for growth (PEG ratio), SRCE offers better value at 0.75x vs HOMB's 4.39x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.0B | $3.1B | $5.3B | $1.8B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $4.0B | $3.4B | $5.6B | $2.1B | $1.8B |
| Trailing P/EPrice ÷ TTM EPS | 12.81x | -7.24x | 13.36x | 11.40x | 14.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.15x | 10.35x | 10.82x | 10.87x | 11.59x |
| PEG RatioP/E ÷ EPS growth rate | 1.96x | — | 4.39x | 0.75x | 2.61x |
| EV / EBITDAEnterprise value multiple | 8.80x | — | 10.12x | 9.64x | 12.62x |
| Price / SalesMarket cap ÷ Revenue | 2.61x | 4.93x | 3.64x | 2.99x | 3.40x |
| Price / BookPrice ÷ Book value/share | 1.12x | 0.84x | 1.36x | 1.36x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 9.85x | 6.88x | 12.53x | 8.41x | 10.76x |
Profitability & Efficiency
SRCE leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
SRCE delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-12 for SFNC. UCB carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to HOMB's 0.30x. On the Piotroski fundamental quality scale (0–9), SRCE scores 8/9 vs SFNC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.1% | -11.6% | +10.9% | +12.4% | +10.2% |
| ROA (TTM)Return on assets | +1.2% | -1.6% | +2.0% | +1.8% | +1.3% |
| ROICReturn on invested capital | +8.2% | -9.1% | +7.2% | +9.7% | +9.3% |
| ROCEReturn on capital employed | +10.3% | -4.2% | +9.8% | +4.0% | +12.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 7 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.06x | 0.19x | 0.30x | 0.26x | 0.16x |
| Net DebtTotal debt minus cash | $3M | $261M | $292M | $271M | $111M |
| Cash & Equiv.Liquid assets | $203M | $380M | $910M | $69M | $72M |
| Total DebtShort + long-term debt | $205M | $641M | $1.2B | $341M | $183M |
| Interest CoverageEBIT ÷ Interest expense | 0.89x | -1.01x | 1.44x | 0.98x | 1.11x |
Total Returns (Dividends Reinvested)
SRCE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SRCE five years ago would be worth $16,454 today (with dividends reinvested), compared to $8,461 for SFNC. Over the past 12 months, SRCE leads with a +24.9% total return vs HOMB's -1.9%. The 3-year compound annual growth rate (CAGR) favors SRCE at 23.6% vs HOMB's 12.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.5% | +14.6% | -3.0% | +19.3% | +14.2% |
| 1-Year ReturnPast 12 months | +23.3% | +16.7% | -1.9% | +24.9% | +17.8% |
| 3-Year ReturnCumulative with dividends | +68.2% | +53.4% | +42.0% | +88.8% | +73.2% |
| 5-Year ReturnCumulative with dividends | +9.7% | -15.4% | +6.6% | +64.5% | +15.9% |
| 10-Year ReturnCumulative with dividends | +109.0% | +25.2% | +58.2% | +154.9% | +146.5% |
| CAGR (3Y)Annualised 3-year return | +18.9% | +15.3% | +12.4% | +23.6% | +20.1% |
Risk & Volatility
Evenly matched — SRCE and GABC each lead in 1 of 2 comparable metrics.
Risk & Volatility
GABC is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than SFNC's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GABC currently trades 98.0% from its 52-week high vs HOMB's 87.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.99x | 1.01x | 0.81x | 0.71x | 0.71x |
| 52-Week HighHighest price in past year | $36.77 | $22.18 | $30.83 | $75.64 | $45.00 |
| 52-Week LowLowest price in past year | $27.23 | $17.00 | $25.68 | $56.89 | $36.55 |
| % of 52W HighCurrent price vs 52-week peak | +91.3% | +96.3% | +87.1% | +97.4% | +98.0% |
| RSI (14)Momentum oscillator 0–100 | 57.2 | 62.3 | 50.3 | 56.4 | 56.0 |
| Avg Volume (50D)Average daily shares traded | 825K | 1.2M | 1.4M | 147K | 142K |
Analyst Outlook
Evenly matched — SFNC and SRCE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: UCB as "Hold", SFNC as "Buy", HOMB as "Hold", SRCE as "Hold", GABC as "Hold". Consensus price targets imply 19.1% upside for HOMB (target: $32) vs 6.1% for SFNC (target: $23). For income investors, SFNC offers the higher dividend yield at 4.00% vs SRCE's 2.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $39.50 | $22.67 | $32.00 | $81.00 | $48.00 |
| # AnalystsCovering analysts | 7 | 9 | 19 | 4 | 8 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | +4.0% | +2.8% | +2.1% | +2.7% |
| Dividend StreakConsecutive years of raises | 9 | 6 | 21 | 30 | 13 |
| Dividend / ShareAnnual DPS | $0.97 | $0.85 | $0.75 | $1.58 | $1.18 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | 0.0% | +1.6% | +0.8% | 0.0% |
SRCE leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). SFNC leads in 1 (Valuation Metrics). 3 tied.
UCB vs SFNC vs HOMB vs SRCE vs GABC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UCB or SFNC or HOMB or SRCE or GABC a better buy right now?
For growth investors, German American Bancorp, Inc.
(GABC) is the stronger pick with 54. 5% revenue growth year-over-year, versus -56. 7% for Simmons First National Corporation (SFNC). 1st Source Corporation (SRCE) offers the better valuation at 11. 4x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate Simmons First National Corporation (SFNC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UCB or SFNC or HOMB or SRCE or GABC?
On trailing P/E, 1st Source Corporation (SRCE) is the cheapest at 11.
4x versus German American Bancorp, Inc. at 14. 4x. On forward P/E, Simmons First National Corporation is actually cheaper at 10. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: 1st Source Corporation wins at 0. 71x versus Home Bancshares, Inc. 's 3. 55x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — UCB or SFNC or HOMB or SRCE or GABC?
Over the past 5 years, 1st Source Corporation (SRCE) delivered a total return of +64.
5%, compared to -15. 4% for Simmons First National Corporation (SFNC). Over 10 years, the gap is even starker: SRCE returned +155. 3% versus SFNC's +24. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UCB or SFNC or HOMB or SRCE or GABC?
By beta (market sensitivity over 5 years), 1st Source Corporation (SRCE) is the lower-risk stock at 0.
71β versus Simmons First National Corporation's 1. 01β — meaning SFNC is approximately 42% more volatile than SRCE relative to the S&P 500. On balance sheet safety, United Community Banks, Inc. (UCB) carries a lower debt/equity ratio of 6% versus 30% for Home Bancshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UCB or SFNC or HOMB or SRCE or GABC?
By revenue growth (latest reported year), German American Bancorp, Inc.
(GABC) is pulling ahead at 54. 5% versus -56. 7% for Simmons First National Corporation (SFNC). On earnings-per-share growth, the picture is similar: United Community Banks, Inc. grew EPS 28. 4% year-over-year, compared to -343. 8% for Simmons First National Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UCB or SFNC or HOMB or SRCE or GABC?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 27. 7% net margin versus -63. 4% for Simmons First National Corporation — meaning it keeps 27. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 36. 0% versus -84. 2% for SFNC. At the gross margin level — before operating expenses — SRCE leads at 70. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UCB or SFNC or HOMB or SRCE or GABC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, 1st Source Corporation (SRCE) is the more undervalued stock at a PEG of 0. 71x versus Home Bancshares, Inc. 's 3. 55x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Simmons First National Corporation (SFNC) trades at 10. 3x forward P/E versus 11. 6x for German American Bancorp, Inc. — 1. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HOMB: 19. 1% to $32. 00.
08Which pays a better dividend — UCB or SFNC or HOMB or SRCE or GABC?
All stocks in this comparison pay dividends.
Simmons First National Corporation (SFNC) offers the highest yield at 4. 0%, versus 2. 1% for 1st Source Corporation (SRCE).
09Is UCB or SFNC or HOMB or SRCE or GABC better for a retirement portfolio?
For long-horizon retirement investors, 1st Source Corporation (SRCE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 2. 1% yield, +155. 3% 10Y return). Both have compounded well over 10 years (SRCE: +155. 3%, SFNC: +24. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UCB and SFNC and HOMB and SRCE and GABC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UCB is a small-cap deep-value stock; SFNC is a small-cap income-oriented stock; HOMB is a small-cap deep-value stock; SRCE is a small-cap deep-value stock; GABC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.